Clinical Trial Update: Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophageal Cancer [Phase 3]

View source ↗

Summary

Phase 3 study evaluating camrelizumab in combination with concurrent chemoradiotherapy for locally advanced esophageal cancer is ongoing; no results disclosed y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Camrelizumab (camrelizumab)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Esophageal Cancer | Phase 3 | Status: UNKNOWN